This site is intended for healthcare professionals only
LoginRegister
Natco Pharma Gets USFDA Tentative Approval for Cancer Drug ErdafitinibNatco Pharma consolidated net profit declines 22 percent at Rs 62 crore in Q3
COVID vaccine: NTAGI holds meeting on Covovax inclusion as heterologous booster for adults on CoWin portalCOVID vaccine: NTAGI holds meeting on Covovax inclusion as heterologous booster for adults on CoWin...
Piramal Pharma reports consolidated net loss of Rs 90 crore in Q3Piramal Pharma reports consolidated net loss of Rs 90 crore in Q3
Serum Institute cervical cancer vaccine CERVAVAC to be available in market this month at Rs 2000 for two doses: SourcesSerum Institute cervical cancer vaccine CERVAVAC to be available in market this month at Rs 2000 for...
Pfizer ropes in Meenakshi Nevatia as MD, Additional DirectorPfizer ropes in Meenakshi Nevatia as MD, Additional Director
Eli Lilly gets CDSCO panel nod to study anticancer drug ImlunestrantEli Lilly gets CDSCO panel nod to study anticancer drug Imlunestrant
Former Roche Executive Bill Anderson to become new CEO of BayerFormer Roche Executive Bill Anderson to become new CEO of Bayer
Abbotts Phensedyl Supply Chain Under Scanner After Ghaziabad Seizure, Codeine Diversion Probe WidensAbbott to buy Cardiovascular Systems for USD 890 million
Lupin Partners with TB Alliance to Advance Telacebec for TB, Leprosy and Buruli UlcerWellmarker Bio enters clinical trial collaboration with MSD to evaluate WM-A1-3389 in combination...
JB Pharma reports revenue growth of 32 percent to Rs 793 crores in Q3 FY23JB Pharma reports revenue growth of 32 percent to Rs 793 crores in Q3 FY23
Lupin unveils Liraglutide Injection in US for diabetesUSFDA nod to Lupin Glycopyrrolate Injection
Takeda concludes acquisition of Nimbus Therapeutics TYK2 Program SubsidiaryTakeda concludes acquisition of Nimbus Therapeutics' TYK2 Program Subsidiary
X